Skip to content
Israel Biotech Fund
  • About
  • Strategy
  • Portfolio
  • Team
  • Advisors
  • Partnerships
  • News
  • Contact
  • Investors
◀︎ All News

SpliSense Secures $28.5 Million in Series B Financing

May 13th, 2021 by IBF

Orbimed, Israel Biotech Fund, Biotel Limited, Integra Holdings and the Cystic Fibrosis Foundation participated in the round.

© 2025 Israel Biotech Fund